BOTHELL, Wash., Feb. 2, 2011 /PRNewswire/ -- Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has been awarded a contract to deploy Powerheart AEDs in all Tyco Flow Control facilities globally. Tyco Flow Control is a $3.4B division of Tyco International, with 15,000 employees working in 350 facilities throughout the globe. The first phase of the rollout, planned for the first quarter of 2011, will equip Tyco’s Australian, Pacific, and North and South American facilities.
(Logo: http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO)
“We are proud to have been selected for Tyco’s ‘Save a Life’ program and look forward to protecting their employees against sudden cardiac arrest,” said Dave Marver, Cardiac Science chief executive officer. “Tyco’s decision reinforces our status as a global leader in AED technology and services.”
“We wanted a fully automatic defibrillator that did not require the user to push a button for shock delivery and an AED that customizes the energy level for each patient,” said Ralf Schnorringer, director of Environmental Health and Safety for Tyco Flow Control. “Cardiac Science’s ability to deliver a globally standardized product and AED program management throughout the world made them our first choice for the ‘Save a Life’ initiative at Tyco Flow Control.”
About Cardiac Science
Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.
For information, contact (media) Anastasia Mironovaamironova@cardiacscience.com +1.425.402.2092 | (investors) ir@optoindia.com | +91.80.2852.8088
SOURCE Cardiac Science Corporation
